Oestrogen and nerve growth factor – neuroprotection and repair in Alzheimer’s disease

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.9, Iss.4, 2000-04, pp. : 685-694

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting the nerve growth factor network in Alzheimer’s disease

By Sykiotis Gerasimos P Papavassiliou Athanasios G

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 3, 2007-03 ,pp. : 267-269

Informa Healthcare

Access to resources Recommend Favorite

Nerve Growth Factor: Structure, Function and Therapeutic Implications for Alzheimer's Disease

Current Drug Targets-CNS & Neurological Disorders, Vol. 2, Iss. 5, 2003-10 ,pp. : 315-334

Bentham Science Publishers

Access to resources Recommend Favorite

Selective in vivo antagonism of endothelin receptors in transforming growth factor-β1 transgenic mice that mimic the vascular pathology of Alzheimer’s disease

By Papadopoulos Panayiota Ongali Brice Hamel Edith

Canadian Journal of Physiology and Pharmacology, Vol. 88, Iss. 6, 2010-06 ,pp. : 652-660

NRC Research Press

Access to resources Recommend Favorite

Alzheimer’s Disease

Cells Tissues Organs, Vol. 162, Iss. 1, 1998-10 ,pp. : 46-55

Karger

Access to resources Recommend Favorite

Subcellular Injuries in Alzheimer’s Disease

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 4, 2014-06 ,pp. : 593-605

Bentham Science Publishers

Access to resources Recommend Favorite